Angela Genge
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Benatar M, Hansen T, Rom D, Geist M, Blaettler T, Camu W, Kuzma-Kozakiewicz M, van den Berg L, Juntas-Morales R, Chio A, Andersen P, Pradat P, Lange D, Van Damme P, Mora G, Grudniak M, Elliott M, Petri S, Olney N, Ladha S, Goyal N, Meyer T, Hanna M, Quinn C, Genge A, Zinman L, Jabari D, Shoesmith C, Ludolph A, Neuwirth C, Nations S, Shefner J, Turner M, Wuu J, Bennett R, Dang H, Sundgreen C, ORARIALS-01 trial team. Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. Lancet Neurol 2024; 23:687-699.
20.05.2024Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
20.05.2024Lancet Neurol 2024; 23:687-699
Benatar Michael, Hansen Thomas, Rom Dror, Geist Marie A, Blaettler Thomas, Camu William, Kuzma-Kozakiewicz Magdalena, van den Berg Leonard H, Juntas-Morales Raul, Chio Adriano, Andersen Peter Munch, Pradat Pierre-Francois, Lange Dale J, Van Damme Philip, Mora Gabriele, Grudniak Mariusz, Elliott Matthew, Petri Susanne, Olney Nicholas, Ladha Shafeeq S, Goyal Namita A, Meyer Thomas, Hanna Michael G, Quinn Colin, Genge Angela, Zinman Lorne, Jabari Duaa, Shoesmith Christen, Ludolph Albert C., Neuwirth Christoph, Nations Sharon, Shefner Jeremy M, Turner Martin R, Wuu Joanne, Bennett Richard, Dang Hoang, Sundgreen Claus, ORARIALS-01 trial team
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
van den Berg L, McDermott C, Pioro E, Rosenfeld J, Silani V, Turner M, Weber M, Brooks B, Miller R, Mitsumoto H, Lomen-Hoerth C, Gubitz A, Genge A, Sorenson E, Gronseth G, Macklin E, Andrews J, Baloh R, Benatar M, Berry J, Chio A, Corcia P, Airlie House ALS Clinical Trials Guidelines Group. Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology 2019; 92:e1610-e1623.
08.03.2019Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
08.03.2019Neurology 2019; 92:e1610-e1623
van den Berg Leonard H, McDermott Christopher J, Pioro Erik P, Rosenfeld Jeffrey, Silani Vincenzo, Turner Martin R, Weber Markus, Brooks Benjamin Rix, Miller Robert G, Mitsumoto Hiroshi, Lomen-Hoerth Catherine, Gubitz Amelie K, Genge Angela, Sorenson Eric, Gronseth Gary, Macklin Eric A, Andrews Jinsy, Baloh Robert H, Benatar Michael, Berry James D, Chio Adriano, Corcia Philippe, Airlie House ALS Clinical Trials Guidelines Group